Table 1 Baseline characteristics of the placebo and treatment (CXL) groups
Placebo group (N = 14) | CXL group (N = 15) | |||
|---|---|---|---|---|
Female Patients | 14 % (2) | 27 % (4) | p = 0.41 | |
Age at inclusion | 25.8 +/−7.4 | 29.5 +/−11.1 | p = 0.55 | |
Centre: | Freiburg | 64 % (9) | 40 % (6) | p = 0.10 |
München | 36 % (5) | 33 % (5) | ||
Würzburg | 0 % (0) | 27 % (4) | ||
Corneal thickness at inclusion | 468.8 +/−25.4 | 466.8 +/−27.8 | p = 0.91 | |
Kmin at inclusion | 46.5 +/−4.3 | 44.0 +/−1.7 | p = 0.07 | |
Kmax at inclusion | 50.9 +/−5.7 | 47.3 +/−2.2 | p = 0.05 | |
Visual acuity at inclusion (logMAR) | 0.39 +/−0.37 | 0.25 +/−0.15 | p = 0.38 |